An introduction to modelling arterial pulse waves
Peter Charlton, University of Cambridge, UK
peterhcharlton.github.io
To do: Please go to this website, find this talk under ‘Talks’, and see the accompanying resources.
I find simulated pulse waves useful for:
- Understanding physiological mechanisms
- Designing algorithms
- Investigating algorithm performance
Part 1
An Introduction to Pulse Wave Modelling using a 1D Model
The Model
Simulated Pulse Waves
Possible Limitations
A few thoughts:
- Periodic inflow, as opposed to normal heart rate variability
- Specified arterial properties, which may not be representative of a particular individual
- Not able to model venous flow
- HR: heart rate
- SV: stroke volume
- LVET: left ventricular ejection time
- PFT: time of peak aortic flow
- RFV: reverse flow volume
- Diam: the diameters of the largest arteries
- PWV: pulse wave velocities
- MAP: mean blood pressure
- PVC: peripheral vascular compliance
Which parameters would be most interesting to change, and why?
Which are most relevant to vascular ageing?
Virtual Subjects
We created:
- Baseline virtual subject at each age
- Virtual subjects at each age with varying cardiovascular properties
- A publicly available database of simulated pulse waves for 4,374 virtual subjects
- Increase in amplitude of second systolic peaks with age
- Disappearance of second peak of finger PPG with age
- Nonetheless, some marked differences between in vivo and simulated waveforms.
For further details of the verification see the accompanying article.
Part 2
Case Study: Assessing Arterial Stiffness from the Photoplethysmogram
Digital Wearable Device
The Photoplethysmogram (PPG)
Changes in PPG Pulse Wave Shape
Assessing Arterial Stiffness
Results
Implications
- Age range
- Influence of HR and SV.
Questions
- What would you think of using this technology to assess vascular age?
- How might it compare to other technologies?
- How could one assess the relative performance of such technologies?
Next Steps
Assessing Vascular Age from the Photoplethysmogram: A Systematic Review from VascAgeNet
Part 3
Case Study: Changes in Pulse Pressure Amplification with Age
Pulse Pressure Amplification
$$\mathrm{Pulse \ Pressure \ Amplification} = \frac{\mathrm{brachial \ pulse \ pressure}}{\mathrm{aortic \ pulse \ pressure}}$$
Questions:
- How does pulse pressure amplification change with age?
- Why?
Methods
Investigated the effects of age on:
- Early systolic amplification (P1)
- Late systolic pressure augmentation (P2)
at the aorta.
Results
Implications
The database can be used to gain insight into the CV determinants of mechanisms of blood flow.
- When might this be helpful?
- How should this approach be used:
- instead of clinical studies
- as well as clinical studies, or
- not at all?
See the following for similar work, investigating the accuracy of methods for assessing pulse wave velocity:
Willemet M et al., A database of virtual healthy subjects to assess the accuracy of foot-to-foot pulse wave velocities for estimation of aortic stiffness, doi: 10.1152/ajpheart.00175.2015
Part 4
Potential studies using blood flow modelling
Exploring potential studies
Think of a study in which pulse wave modelling could be useful.
Consider:
- Research question
- What would need to be simulated?
- Under what conditions?
- In which ways would the model need to be particularly accurate?
Limitations
- Dependent on model accuracy
- Which in turn, is dependent on input parameters
- Often requires specialist knowledge to perform studies
Benefits
- Allows pulse waves to be simulated under different conditions
- Control of physiology
- Free of measurement error
- Potentially cheap, and doesn’t require participant involvement
Opportunities
- Preliminary pilot work in technology development
- Inform the design of in vivo studies
- Understand the potential shortcomings of existing technologies
- Understand the mechanisms underlying haemodynamic observations
Further Resources
See the following:
Acknowledgment
None of this would have been possible without:
- Dr Jordi Alastruey-Arimon, who provided the model and supervision
- The British Heart Foundation, who funded the work
- COST Action CA18216 “Network for Research in Vascular Ageing” supported by COST (European Cooperation in Science and Technology)